<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - [REDACTED]</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">REASON FOR VISIT</a></li><li><a href="#id3">Medications</a></li><li><a href="#id4">Social History</a></li><li><a href="#id5">Vital Signs</a></li><li><a href="#id6">Encounters</a></li><li><a href="#id7">Assessments</a></li><li><a href="#id8">Plan Of Treatment</a></li><li><a href="#id9">Medications Administered</a></li><li><a href="#id10">Progress Notes</a></li><li><a href="#id11">History and Physical Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><span class="content_span">No Known Allergies</span></div><h3><a name="id2" href="#toc">REASON FOR VISIT</a></h3><div>Follow-up prostate cancer, [REDACTED] 22.5mg Injection</div><h3><a name="id3" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Benazepril HCl 20 MG</td><td ID="instruction1">1 tablet Orally Once a day for 30 day(s)</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">oxyCODONE-Acetaminophen 10-325 MG</td><td ID="instruction2">1 tablet as needed Orally every 6 hrs</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication3">Desipramine HCl 10 MG</td><td ID="instruction3"> Oral for 90</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication4">LORazepam 1 MG</td><td ID="instruction4">1 tablet as needed Orally Twice a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication5">Desipramine HCl 10 MG</td><td ID="instruction5">TAKE TWO TABLETS BY MOUTH AT BEDTIME Oral for Not Available</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication6">Naloxone HCl 4 MG/0.1ML</td><td ID="instruction6">CALL 911. SPR CONTENTS OF ONE SPRAYER (0.1ML) INTO ONE NOSTRIL. REPEAT IN 2-3 MIN IF SYMPTOMS OF OPIOID EMERGENCY PERSIST, ALTERNATE NOSTRILS Nasal for 1</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication7">Lupron Depot (3-Month) 22.5 MG</td><td ID="instruction7">as directed Intramuscular every 24 weeks for 168 day(s)</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication8">Morphine Sulfate ER 15 MG</td><td ID="instruction8">(Schedule II Drug) TAKE 1 TABLET BY MOUTH 3 TIMES A DAY Oral for 30</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Social History</a></h3><div><span class="content_span">Tobacco Use:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th><th>Date</th></tr></thead><tbody><tr><td ID="smokingStatus1">Details (start date - stop date)</td><td>Never Smoker</td><td>NA - NA</td></tr></tbody></table><span class="content_span">Tobacco Use/Smoking</span><table ID="socialhistorynotes" width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Are you a</td><td>nonsmoker</td><td/></tr><tr><td>Additional Findings: Tobacco Non-User</td><td>Current non-smoker</td><td/></tr></tbody></table><span class="content_span">Alcohol Screen (Audit-C)</span><table width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Did you have a drink containing alcohol in the past year?</td><td>No</td><td/></tr><tr><td>Points</td><td>0</td><td/></tr><tr><td>Interpretation</td><td>Negative</td><td/></tr></tbody></table><span class="content_span">Tobacco use other than smoking:</span><table width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Are you an other tobacco user?</td><td>No</td><td/></tr></tbody></table></div><h3><a name="id5" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Height</th><td>5 ft 11 in in</td><td>[REDACTED]</td></tr><tr><th ID="vital2">Blood pressure systolic</th><td> 127 mm Hg</td><td>[REDACTED]</td></tr><tr><th ID="vital3">Blood pressure diastolic</th><td>71 mm Hg</td><td>[REDACTED]</td></tr><tr><th ID="vital4">Temperature</th><td>97.2 degrees Fahrenheit</td><td>[REDACTED]</td></tr><tr><th ID="vital5">Heart Rate</th><td>68 /min</td><td>[REDACTED]</td></tr><tr><th ID="vital6">Weight</th><td>139 lb 8 oz lbs</td><td>[REDACTED]</td></tr><tr><th ID="vital7">BMI</th><td>19.45 kg/m2</td><td>[REDACTED]</td></tr></tbody></table></div><h3><a name="id6" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>Urology Professionals Of South [REDACTED] LLC</td><td>[REDACTED][REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Malignant neoplasm of prostate C61</td></tr></tbody></table></div><h3><a name="id7" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th><th>Section Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>Malignant neoplasm of prostate (ICD-10 - C61)</td><td/><td>Rising PSA. Recheck PSA [REDACTED]. May consider going back to every 3 months.</td><td/><td/></tr></tbody></table></div><h3><a name="id8" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Treatment Notes</span><table width="100%" border="1"><thead><tr><th>Assessment</th><th>Notes</th></tr></thead><tbody><tr><td ID="instructionpot1">Malignant neoplasm of prostate</td><td>Rising PSA. Recheck PSA [REDACTED]. May consider going back to every 3 months.</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="nextAppt">Follow Up: 3 months, Reason: PSA result</td></tr></tbody></table></div><h3><a name="id9" href="#toc">Medications Administered</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>Instructions</th><th>Date of Administration</th><th>Dosage</th><th>Notes</th></tr></thead><tbody><tr><td ID="therapeuticinjection1">LUPRON (Leuprolide Acetate 22.5 MG)</td><td/><td>[REDACTED]</td><td>22.5 mg</td><td/></tr></tbody></table></div><h3><a name="id10" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>[REDACTED] <span class="bold">DOB:</span> [REDACTED] ([REDACTED] M) <span class="bold">Acc No.</span> 21770 <span class="bold">DOS:</span> [REDACTED]</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold">Progress Note</span></td></tr><tr><td align="left"><span class="bold">Patient: </span>[REDACTED]<br/><span class="bold">Account Number: </span>21770</td><td align="right"><span class="bold">Provider: </span>[REDACTED], MD</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>[REDACTED]<span class="bold">   Age: </span>74 Y<span class="bold">   Sex: </span>Male</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td><span class="bold">Phone: </span>[REDACTED]</td></tr><tr><td colspan="2"><span class="bold">Address: </span>[REDACTED][REDACTED]</td></tr><tr><td colspan="2"><span class="bold">Pcp: </span>[REDACTED], MD </td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   Follow-up prostate cancerLupron Depot 22.5mg Injection</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">New/Follow-up Patient Consult</span>: <br/>       [REDACTED][REDACTED] male with Hx HTN, chronic back pain, and recurrent prostate cancer after radical prostatectomy several years ago. presents to clinic from routine follow up for lupron injection. Patient states that he is not having any trouble urinating but has to get up about two times during the night to urinate.<br/>[REDACTED] PSA 11.8 - patient referred to us.<br/>Hormonal therapy was recommended and after contemplating for some time, he agreed to the treatment.<br/>[REDACTED] - Pt received just one dose of Lupron after which he decided not to continue.<br/>[REDACTED] PSA down to 1.3 - we did not see him From 04/2016 until late 2017 - patient no show. 04/2017 PSA up again to 11.7 - Pt decided to resume treatment.<br/>06/2018 PSA down to 0.6 - Pt c/o unbearable hot flashes and decided to suspend treatment once again.<br/>[REDACTED]) PSA up again, to 2.6<br/>12/2018 PSA higher still, to 9.2<br/>[REDACTED] - resumed treatment, then missed several more appointments.<br/>[REDACTED] - resumed treatment again<br/>PSA has been trending down again<br/>[REDACTED] PSA 0.5<br/>[REDACTED] PSA 0.5<br/>[REDACTED] PSA 0.5<br/>[REDACTED] injection #7<br/>[REDACTED] Injection #8<br/>[REDACTED]: injection #9 PSA 0.4 ([REDACTED])<br/>He is c/o severe hot flashes, perspirations, soaking wet.<br/>[REDACTED]: Lupron #10, PSA [REDACTED] - 0.4.<br/>[REDACTED]: Lupron # 11 PSA [REDACTED] 0.3<br/>C/o of hot flashes daily<br/>Suspended Lupron and rechecked the PSA<br/>[REDACTED] PSA 0.4<br/>[REDACTED]: No complaints.<br/>[REDACTED]: No specific complaints<br/>[REDACTED] PSA 0.5<br/>Given lupron, will skip next one.<br/>[REDACTED]: for lupron<br/>[REDACTED] PSA: 0.7.<br/>[REDACTED] PSA: 1.1<br/>[REDACTED]: Now on 6-monthly schedule.Concerned about rise in PSA. Lupron given left gluteus.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">ROS:</span> <br/>   <span class="Underline">All Other Systems</span>: <br/>      Review of Systems (ROS) See HPI for details, All others negative except those mentioned in HPI.   <br/>   </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Surgical History:</span> Cervical spine Radical perineal prostatectomy 2005</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Hospitalization/Major Diagnostic Procedure:</span> Prostate cancer surgery, c-spine surgery </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Family History:</span> Spouse: deceased, Expired on [REDACTED]. Siblings: deceased, Brother, from prostate cancer. 2 son(s) , 3 daughter(s)  - healthy. . </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Social History:</span> <br/>   <span class="Underline">Tobacco Use:</span> Tobacco Use/Smoking Are you a <span class="bold">nonsmoker</span>, Additional Findings: Tobacco Non-User <span class="bold">Current non-smoker</span>. Tobacco use other than smoking Are you an other tobacco user? <span class="bold">No</span>. <br/>   <span class="Underline">Drugs/Alcohol:</span> Drugs Have you used drugs other than those for medical reasons in the past 12 months? <span class="bold">No</span>. Alcohol Screen (Audit-C) Did you have a drink containing alcohol in the past year? <span class="bold">No</span>, Points <span class="bold">0</span>, Interpretation <span class="bold">Negative</span>. Caffeine Intake: <span class="bold">none</span>. Do you smoke marijuana?: Denies. Do you drink alcohol?: No. <br/>   <span class="Underline">Miscellaneous:</span> Exercise: none. Living with: alone. Marital status: in relationship with female partner. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> TakingLupron Depot (3-Month) 22.5 MG Kit as directed Intramuscular every 24 weeks Naloxone HCl 4 MG/0.1ML Liquid CALL 911. SPR CONTENTS OF ONE SPRAYER (0.1ML) INTO ONE NOSTRIL. REPEAT IN 2-3 MIN IF SYMPTOMS OF OPIOID EMERGENCY PERSIST, ALTERNATE NOSTRILS Nasal  Morphine Sulfate ER 15 MG Tablet Extended Release (Schedule II Drug) TAKE 1 TABLET BY MOUTH 3 TIMES A DAY Oral  oxyCODONE-Acetaminophen 10-325 MG Tablet 1 tablet as needed Orally every 6 hrs Benazepril HCl 20 MG Tablet 1 tablet Orally Once a day LORazepam 1 MG Tablet 1 tablet as needed Orally Twice a day Desipramine HCl 10 MG Tablet  Oral  Desipramine HCl 10 MG Tablet TAKE TWO TABLETS BY MOUTH AT BEDTIME Oral  Medication List reviewed and reconciled with the patientTaking Lupron Depot (3-Month) 22.5 MG Kit as directed Intramuscular every 24 weeks Taking Naloxone HCl 4 MG/0.1ML Liquid CALL 911. SPR CONTENTS OF ONE SPRAYER (0.1ML) INTO ONE NOSTRIL. REPEAT IN 2-3 MIN IF SYMPTOMS OF OPIOID EMERGENCY PERSIST, ALTERNATE NOSTRILS Nasal  Taking Morphine Sulfate ER 15 MG Tablet Extended Release (Schedule II Drug) TAKE 1 TABLET BY MOUTH 3 TIMES A DAY Oral  Taking oxyCODONE-Acetaminophen 10-325 MG Tablet 1 tablet as needed Orally every 6 hrs Taking Benazepril HCl 20 MG Tablet 1 tablet Orally Once a day Taking LORazepam 1 MG Tablet 1 tablet as needed Orally Twice a day Taking Desipramine HCl 10 MG Tablet  Oral  Taking Desipramine HCl 10 MG Tablet TAKE TWO TABLETS BY MOUTH AT BEDTIME Oral  Medication List reviewed and reconciled with the patient</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Allergies:</span> N.K.D.A.no[Allergies Verified]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> Temp: <span class="bold">97.2</span> F, HR: <span class="bold">68</span> /min, BP: <span class="bold">sitting: 127/71</span> mm Hg, Wt: <span class="bold">139 lb 8 oz</span>, BMI: <span class="bold">19.45</span> Index, Ht: 5 ft 11 in, Pain scale: <span class="bold">0</span> 1-10, Ht-cm: 180.34 cm.<br/></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content class="bold">Examination: <br/></content>   <span class="Underline">General Examination:</span><br/>      GENERAL APPEARANCE: alert, in no acute distress. <br/>      HEAD: normocephalic, atraumatic.    <br/></td></tr><tr><td/></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. Malignant neoplasm of prostate - C61 (Primary)   </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. Malignant neoplasm of prostate</span> <br/>Notes: Rising PSA. Recheck PSA [REDACTED]. May consider going back to every 3 months.  </td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Therapeutic Injections:</span>    <br/>LUPRON (Leuprolide Acetate 22.5 MG) : 22.5 mg (Dose No:1) (Route: Intramuscular) given by [REDACTED] , MD  on left gluteus</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Procedure Codes:</span> 96402 CHEMO HORMON ANTINEOPL SQ/IM</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Follow Up:</span> 3 months (Reason: PSA result)</td></tr></tbody></table></li></ul><ul><li/></ul><br/><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top"/></tr><tr><td/></tr><tr><td/></tr><tr><td valign="top">Electronically signed by [REDACTED] , MD  on [REDACTED] 05:42 PM EDT</td></tr><tr><td valign="top">Sign off status: Completed</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span">true</span></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> [REDACTED], MD</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td/><td align="right"><span class="content_span">Generated for Printing/Faxing/eTransmitting on: [REDACTED] 12:27 PM EST</span></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><h3><a name="id11" href="#toc">History and Physical Notes</a></h3><div><ul><li><p>Examination</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th><th>Category Notes</th></tr></thead><tbody><tr><td rowspan="2">General Examination</td><td>GENERAL APPEARANCE:</td><td colspan="2">alert, in no acute distress</td><td rowspan="2"/></tr><tr><td>HEAD:</td><td colspan="2">normocephalic, atraumatic</td></tr></tbody></table><br/></li></ul></div><br/><br/>
</body></html>